CC&C News
Results for the 2nd Quarter 2019
- FOLLOWING THE FAILURE OF OUR APPLICATION FOR A EUROPEAN SUBSIDY, ONE OF OUR SHAREHOLDER COMMITS TO RAISE THE BUDGET FOR PROOF OF EFFICACY - CC & C RECEIVES DELIVERANCE OF ITS PATENT FOR JAPAN AND THE USA On June 20th, we received the notification of rejection of...
read moreResults for the 1st Quarter 2019
- SHAREHOLDERS TO APPROVE TOD FINANCES' INVESTMENT IN CC&C - CC & C GETS CERTIFICATION BY ITS COMPETITIVENESS CLUSTER We held our General Assembly on May 9th.This was mainly an opportunity to ratify family office “TOD Finances” investment in the company....
read moreResults for the 4th quarter 2018
- PARTICIPATION IN CC & C - NEWS OF OUR RESEARCH PROJECTS TOD Finances, a french family office, is expected to invest 100,000 euros in our company by the end of February. This excellent news will allow us to hire a new researcher and launch new projects. In...
read more
2017 press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2016 press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2015 and before press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2018 press releases
Results for the 4th quarter 2018
- PARTICIPATION IN CC & C - NEWS OF OUR RESEARCH PROJECTS TOD Finances, a french family office, is expected to invest 100,000 euros in our company by the end of February. This excellent news will allow us to hire a new researcher and launch new projects. In...
read moreResults for the 3rd quarter 2018
- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...
read more
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles
CC&C news
Results for the 2nd Quarter 2019
- FOLLOWING THE FAILURE OF OUR APPLICATION FOR A EUROPEAN SUBSIDY, ONE OF OUR SHAREHOLDER COMMITS TO RAISE THE BUDGET FOR PROOF OF EFFICACY - CC & C RECEIVES DELIVERANCE OF ITS PATENT FOR JAPAN AND THE USA On June 20th, we received the notification of rejection of...
read moreResults for the 1st Quarter 2019
- SHAREHOLDERS TO APPROVE TOD FINANCES' INVESTMENT IN CC&C - CC & C GETS CERTIFICATION BY ITS COMPETITIVENESS CLUSTER We held our General Assembly on May 9th.This was mainly an opportunity to ratify family office “TOD Finances” investment in the company....
read moreResults for the 4th quarter 2018
- PARTICIPATION IN CC & C - NEWS OF OUR RESEARCH PROJECTS TOD Finances, a french family office, is expected to invest 100,000 euros in our company by the end of February. This excellent news will allow us to hire a new researcher and launch new projects. In...
read more
2017 press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2016 press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2015 and before press review
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2017 press releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2016 press releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
2015 and before press releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles